Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
QuintilesIMS
Chinese Patent Office
US Army
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission
Dow

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074086

« Back to Dashboard

NDA 074086 describes DOBUTAMINE HYDROCHLORIDE, which is a drug marketed by Baxter Hlthcare, Hospira, Luitpold, Teligent Pharma Inc, Teva Parenteral, Watson Labs, Watson Labs Inc, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from three suppliers. Additional details are available on the DOBUTAMINE HYDROCHLORIDE profile page.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
Summary for 074086
Tradename:DOBUTAMINE HYDROCHLORIDE
Applicant:Hospira
Ingredient:dobutamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 074086
Mechanism of ActionAdrenergic beta-Agonists
Medical Subject Heading (MeSH) Categories for 074086
Suppliers and Packaging for NDA: 074086
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074086 ANDA Hospira, Inc. 0409-2344 N 0409-2344-88
DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074086 ANDA Hospira, Inc. 0409-2344 N 0409-2344-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 12.5MG BASE/ML
Approval Date:Nov 29, 1993TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
Cipla
Teva
Chubb
McKesson
Deloitte
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.